Navigation Links
Global Coronary Stents Industry
Date:12/8/2011

Drug-Eluting Stents by Company 31

Drugs for Coating DESs 31

Cytotoxic or Cytostatic Drug - the Debate Continues 32

Dosing and Deliverability Crucial for DES 32

Polymer Coatings for Effective Dosing and Deliverability 32

Drugs Used for DES by Major Competitors in the Stent Market 32

Leading Coronary Stent Brands 33

Cypher 33

Structure and Delivery Mechanism 33

Taxus 34

Structure and Delivery Mechanism 34

8. RESEARCH AND DEVELOPMENT 35

Extensive R&D Underway in Global Drug-Eluting Stents Market 35

At the Labs 35

Other Products Under Trials - A Recent Past Perspective 35

OMT Developing R-stent 35

Reva Developing Stainless Steel Bare-Metal Stent 35

D&P Corp Developing Bovine Pericardium- Covered Stent 36

Advanced Bio Synthesizing Porous Drug-Eluting Stents 36

Lombard Medical Developing PEP Coatings 36

Shiga Develops Biodegradable Drug-Eluting Stent 36

9. PRODUCT INNOVATIONS/INTRODUCTIONS 37

Boston Scientific Launches ION™ Platinum Chromium Stent System 37

Terumo Introduces Nobori Drug-Eluting Coronary Stent 37

Boston Scientific Unveils TAXUS® Element™ and PROMUS® Element™

Stent Systems 37

Covidien Introduces EverFlex+™ Self-Expanding Peripheral Stent

System 38

Boston Scientific Launches Taxus Element Stent System in

European Union 38

Cordis Introduces PRESILLION™ PLUS Stent System in Europe 38

Medtronic Launches Resolute Integrity Stent System 38

InspireMD Unveils MGuard Prime 39

Boston Scientific Introduces Taxus Eluting Stent System 39

Boston Scientific Unveils TAXUS Liberte Paclitaxel Eluting

Stent System in Japan 39

Alvimedica Launches Coracto Drug-Eluting Stent in Europe 39

Abbott Labs to Launch XIENCE V in China 40

Medtronic Launches Driver Sprint RX Coron
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Paragon 28, ... commercial launch of its foot plating system that supplants ... The GORILLA TM R3CON PLATING SYSTEM greatly enhances ... TM & Mini-Monster TM Screw Systems and ... of 10 interchangeable subsystems, the GORILLA TM R3CON ...
(Date:9/22/2014)... 2014 Research and Markets  has announced ... 2014-2018" report to their offering. ... comprehensive and up-to-date publication available covering the neurotechnology industry. ... markets, competitors, and growth rates in four key segments ... 2018. It forecasts the number of systems to be ...
(Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, Inc. ... treat infectious disease, today announced it has completed ... of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin in ... data from these studies support the safety and ... at the intended therapeutic dose. The conclusion of ...
Breaking Medicine Technology:Paragon 28, Inc. Launches the GORILLA(TM) R3CON PLATING SYSTEM 2The Market for Neurotechnology: 2014-2018 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6
... 20 Muscadine grape skin powder, from ... /), provided significant protection against radiation damage in an ... reported in April of 2009 at the 100th Annual ... Denver, Colorado.(Logo: http://www.newscom.com/cgi-bin/prnh/20090420/CL01715 )The ...
... prototype 3D display exceeds performance expectations.LIVONIA, Mich., April 20 ... Heritage Hospital surgeons and their medical support team assembled to ... test the new LifeVision(TM) family of 3D technologies developed by ... event marks the first time in history that ...
Cached Medicine Technology:Muscadine Grape Skin Dietary Supplement Protects against Cancer Therapy Radiation Side Effects 2Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 2Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 3Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 4
(Date:9/23/2014)... Village, CA (PRWEB) September 23, 2014 ... Dental Office is now offering complimentary oral sedation with ... 15 percent of Americans suffer from dental anxiety or ... uncomfortable for patients; they can also keep patients from ... anxiety or phobia in Westlake Village and surrounding areas ...
(Date:9/23/2014)... YORK, NY (PRWEB) September 23, 2014 ... best innovators in the pharmaceutical industry with their annual ... bestowed at a gala banquet at Gotham Hall in ... and brand managers representing top talent and brands. ... celebrate its accomplishments,” says Anna Stashower, CEO and Publisher ...
(Date:9/23/2014)... Gurnee, IL (PRWEB) September 23, 2014 ... lighting solutions, has expanded its MedMaster™ M4 product ... The luminaire extends the M4 product line – ... green LED options – providing more flexibility when ... of the MedMaster M4 Series include:, ...
(Date:9/23/2014)... 2014 The U.S. Pharmacopeial Convention (USP) ... Health Organization (WHO) regarding the assignment of Biological Qualifiers ... by the Expert Group of the Programme of International ... to the naming of all biologicals that is consistent ... assessment of these drugs. , Hence, USP supports ...
(Date:9/23/2014)... N.J. (PRWEB) September 23, 2014 ... provider of advanced delivery technologies and development ... products, today announced that it had reached ... privately held biopharmaceutical company, Cingulate Therapeutics (CTx), ... of new prescription pharmaceutical products for the ...
Breaking Medicine News(10 mins):Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 2Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 2Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 4Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 5Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 6Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 3Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 3
... , TUESDAY, March 22 (HealthDay News) -- The death ... and were in remission two years after treatment was similar ... study shows. Italian researchers collected data on 832 patients ... and found that 20 patients died during the follow-up period. ...
... HealthDay Reporter , TUESDAY, March 22 (HealthDay News) -- ... on the rise in the United States despite research that ... say. Fibrates are often prescribed to people with low ... triglycerides, a harmful form of fat circulating in the blood, ...
... , TUESDAY, March 22 (HealthDay News) -- A low-cost ... of 400 seemingly healthy children and teens in a pilot ... screen all school-aged children for heart conditions that can lead ... Children,s Hospital of Philadelphia said in a hospital news release. ...
... , TUESDAY, March 22 (HealthDay News) -- Depression can worsen ... South Korean researchers used X-rays to assess the severity ... and older. The patients were also evaluated for the severity ... of pain were higher in patients whose X-rays showed greater ...
... and welfare reforms, and their use of ,nudge, theory, hark ... of the nineteenth century, according to studies by a University ... in the Lancet . Dr Kim Price,s article ... his second in the Lancet within a year drawing parallels ...
... researchers find when women explore their feelings about being or ... humorous. Findings from the project entitled ,Look at me! Images ... feelings about images of ageing. These findings are presented in ... April. Ageing is undoubtedly about the body, and pressure ...
Cached Medicine News:Health News:Leukemia Patients Taking Gleevec Achieve 'Normal' Death Rate 2Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 2Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 3Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 4Health News:Screening Seems to Catch Dangerous Heart Condition in Kids 2Health News:Depression May Boost Arthritis Pain 2Health News:Report indicates that 'new' welfare reforms hark back to Victorians 2Health News:Look at me! 2Health News:Look at me! 3Health News:Look at me! 4
Ribbon malleable, general purpose retractor....
The Wire Cutters are designed to cut Kirschner wires up to 2.5 mm diameter easily and smoothly. They are particularly useful for external fixation applications. The Wire Cutters shear fixation wires ...
The osteotome shafts are manufactured with stainless steel and are available both straight and curved in 1/4" and 1/2" sizes....
... Pulse CDC Compact Cardiac Digital Camera is a ... open, patient-friendly gantry, and provides full sized fields ... into your clinic you need a flexible system ... Find out how the Pulse reduces the ...
Medicine Products: